| 1 | Autologous CD34+ cell transduced with G2SCID vector | - | - | - | - | [1] 65 65 |
| 2 | AUTOLOGOUS CD34+ CELLS TRANSDUCED EX-VIVO WITH THE PCCLCHIMGP91/VSVG LENTIVIRAL VECTOR | - | - | - | - | [1] 65 65 |
| 3 | AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING THE HUMAN SGSH GENE | - | - | - | - | [1] 19 19 |
| 4 | Autologous CD34+ cells transduced with a lentiviral vector encoding the ARSA cDNA | - | - | - | - | [1] 19 19 |
| 5 | AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH LENTI-D VECTOR ENCODING ABCD1 CDNA | - | - | - | - | [1] 20 20 |
| 6 | Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy | - | - | - | - | [1] 65 65 |
| 7 | Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence | - | - | - | - | [1] 65 65 |
| 8 | Autologous CD34+ HSCs transduced ex vivo with EFS lentiviral vector encoding for the human ADA gene | - | - | - | - | [1] 65 65 |
| 9 | AUTOLOGOUS CD34+CELLS TRANSDUCED WITH THE W1.6_HWASP_WPRE (VSVG) LENTIVIRAL VECTOR | - | - | - | - | [1] 65 65 |
| 10 | Autologous CD34+HPC transplantation (HSCT) | - | - | - | - | [1] 49 49 |
| 11 | CD34+ | - | - | - | - | [1] 65 65 |
| 12 | CD34+ bone marrow stem cells intravitreal | - | - | - | - | [1] 90 90 |
| 13 | CD34+ CELLS | - | - | - | - | [1] 285 285 |
| 14 | CD34+ cells transduced with ADA retrovir | - | - | - | - | [1] 65 65 |
| 15 | CD34+ enriched, T Cell Depleted donor stem cell product | - | - | - | - | [1] 326 326 |
| 16 | CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1a-h?c-OPT | - | - | - | - | [1] 65 65 |
| 17 | CD34+ Peripheral Blood Stem Cell Reinfusion | - | - | - | - | [1] 49 49 |
| 18 | CD34+ selected cells | - | - | - | - | [1] 285 285 |
| 19 | CD34+CELLS | - | - | - | - | [2] 65 65, 285 |
| 20 | CD34+SC | - | - | - | - | [1] 51 51 |
| 21 | Cellule CD34+ autologhe trasdotte con IDUA LV codificante per il cDNA dell'alfa-L-iduronidasi | - | - | - | - | [1] 19 19 |
| 22 | CRYOPRESERVED AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING HUMAN SGSH GENE | - | - | - | - | [1] 19 19 |
| 23 | Cryopreserved EFS-ADA LV transduced patient CD34+ cells | - | - | - | - | [1] 65 65 |
| 24 | Cryopreserved G2SCID lentiviral vector transduced patient CD34+ cells | - | - | - | - | [1] 65 65 |
| 25 | Cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant | - | - | - | - | [1] 62 62 |
| 26 | EF1aS-ADA lentiviral vector gene modified autologous CD34+ cells | - | - | - | - | [1] 65 65 |
| 27 | EF1aS-ADA lentiviral vector transduced patient CD34+ cells | - | - | - | - | [1] 65 65 |
| 28 | Ex vivo culture and transduction of the patient's autologous CD34+ HSC with lentivirus vector VSV-G pseudotyped CL20- 4i-EF1alpha-hgammac-OPT vector | - | - | - | - | [1] 65 65 |
| 29 | G1XCGD transduced CD34+ cells | - | - | - | - | [1] 65 65 |
| 30 | Gene-Transduced Autologous CD34+ Stem Cells | - | - | - | - | [1] 65 65 |
| 31 | Genetic: Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101) | - | - | - | - | [1] 65 65 |
| 32 | Genetic: Infusion of autologous EFS-ADA LV CD34+ (OTL-101) | - | - | - | - | [1] 65 65 |
| 33 | Genetic: Infusion of autologous EFS-ADA LV CD34+ cells | - | - | - | - | [1] 65 65 |
| 34 | Intravitreal autologous CD34+ cells | - | - | - | - | [1] 90 90 |
| 35 | Lentiviral vector transduced CD34+ cells | - | - | - | - | [1] 65 65 |
| 36 | RAG1 LV CD34+ cells | - | - | - | - | [1] 65 65 |
| 37 | Retroviral SF71-gp91phox transduced CD34+ cells | - | - | - | - | [1] 65 65 |
| 38 | Suspension of autologous CD34+cells transduced with the G1XCGD viral vector | - | - | - | - | [1] 65 65 |
| 39 | T-Cell Depleted & CD34+Select/w/StemCell Enriched Product | - | - | - | - | [1] 65 65 |
| 40 | Transduced CD34+ Cells | - | - | - | - | [1] 285 285 |
| 41 | Transduced patient CD34+ cells | - | - | - | - | [1] 65 65 |